Literature DB >> 11343654

Functional interaction of the active zone proteins Munc13-1 and RIM1 in synaptic vesicle priming.

A Betz1, P Thakur, H J Junge, U Ashery, J S Rhee, V Scheuss, C Rosenmund, J Rettig, N Brose.   

Abstract

Synaptic neurotransmitter release is restricted to active zones, where the processes of synaptic vesicle tethering, priming to fusion competence, and Ca2+-triggered fusion are taking place in a highly coordinated manner. We show that the active zone components Munc13-1, an essential vesicle priming protein, and RIM1, a Rab3 effector with a putative role in vesicle tethering, interact functionally. Disruption of this interaction causes a loss of fusion-competent synaptic vesicles, creating a phenocopy of Munc13-1-deficient neurons. RIM1 binding and vesicle priming are mediated by two distinct structural modules of Munc13-1. The Munc13-1/RIM1 interaction may create a functional link between synaptic vesicle tethering and priming, or it may regulate the priming reaction itself, thereby determining the number of fusion-competent vesicles.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11343654     DOI: 10.1016/s0896-6273(01)00272-0

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  152 in total

1.  A post-docking role for active zone protein Rim.

Authors:  S P Koushika; J E Richmond; G Hadwiger; R M Weimer; E M Jorgensen; M L Nonet
Journal:  Nat Neurosci       Date:  2001-10       Impact factor: 24.884

2.  Rab3-interacting molecule gamma isoforms lacking the Rab3-binding domain induce long lasting currents but block neurotransmitter vesicle anchoring in voltage-dependent P/Q-type Ca2+ channels.

Authors:  Yoshitsugu Uriu; Shigeki Kiyonaka; Takafumi Miki; Masakuni Yagi; Satoshi Akiyama; Emiko Mori; Akito Nakao; Aaron M Beedle; Kevin P Campbell; Minoru Wakamori; Yasuo Mori
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

Review 3.  Presynaptic frequency- and pattern-dependent filtering.

Authors:  Alex M Thomson
Journal:  J Comput Neurosci       Date:  2003 Sep-Oct       Impact factor: 1.621

Review 4.  Regulation of vesicle traffic and neurotransmitter release in isolated nerve terminals.

Authors:  Wim E J M Ghijsen; A G Miriam Leenders; Fernando H Lopes da Silva
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

5.  A family of RIM-binding proteins regulated by alternative splicing: Implications for the genesis of synaptic active zones.

Authors:  Yun Wang; Xinran Liu; Thomas Biederer; Thomas C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

6.  Munc13-4 is an effector of rab27a and controls secretion of lysosomes in hematopoietic cells.

Authors:  Maaike Neeft; Marnix Wieffer; Arjan S de Jong; Gabriela Negroiu; Corina H G Metz; Alexander van Loon; Janice Griffith; Jeroen Krijgsveld; Nico Wulffraat; Henriette Koch; Albert J R Heck; Nils Brose; Monique Kleijmeer; Peter van der Sluijs
Journal:  Mol Biol Cell       Date:  2004-11-17       Impact factor: 4.138

Review 7.  Enlightening molecular mechanisms through study of protein interactions.

Authors:  Josep Rizo; Michael K Rosen; Kevin H Gardner
Journal:  J Mol Cell Biol       Date:  2012-06-26       Impact factor: 6.216

Review 8.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

9.  Convergent, RIC-8-dependent Galpha signaling pathways in the Caenorhabditis elegans synaptic signaling network.

Authors:  Nicole K Reynolds; Michael A Schade; Kenneth G Miller
Journal:  Genetics       Date:  2004-10-16       Impact factor: 4.562

10.  RIM1alpha and RIM1beta are synthesized from distinct promoters of the RIM1 gene to mediate differential but overlapping synaptic functions.

Authors:  Pascal S Kaeser; Hyung-Bae Kwon; Chiayu Q Chiu; Lunbin Deng; Pablo E Castillo; Thomas C Südhof
Journal:  J Neurosci       Date:  2008-12-10       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.